Qiagen (QGEN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.62
- EPS estimate
- $0.60
- EPS surprise
- +3.64%
- Revenue surprise
- +1.47%
- Revenue
- $535.0M
- Revenue estimate
- $527.3M
- Reported
- Aug 7, 2026
Qiagen reported Q2 2026 results on August 7, 2026. Earnings per share were $0.62, ahead of the $0.60 estimate by 3.64%. Revenue was $535.0 million, above the $527.3 million consensus. Compared with Q2 2025, EPS slipped about 2% from $0.63, while revenue was nearly flat, up 0.3% from $533.5 million.
The longer record is steady rather than fast-growing. Annual EPS was $2.64 in 2022, $2.30 in 2023, $2.36 in 2024 and $2.47 in 2025. The first half of 2026 adds up to $1.16, about 4% below the $1.21 of the same period a year earlier. Q1 2022 holds the highs in the table, at $0.89 per share and $628.4 million in revenue. Since then, quarterly EPS has stayed between $0.50 and $0.64. Over the last 20 quarters, Qiagen beat the EPS estimate 16 times, and its four misses were all within about 1%.
Qiagen reported Q3 results between November 1 and November 9 in each of the past five years. That points to early November 2026 for the next report. It will show whether EPS returns to year-over-year growth after three quarters below the prior year.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $0.60 | $0.62 | +3.64% | $535.0M | SEC |
| Q1 2026 | May 1, 2026 | $0.54 | $0.54 | −0.39% | $492.0M | SEC |
| Q4 2025 | Feb 6, 2026 | $0.60 | $0.62 | +2.96% | $540.4M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.62 | $0.64 | +4.19% | $533.0M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.63 | $0.63 | −0.38% | $533.5M | SEC |
| Q1 2025 | May 9, 2025 | $0.53 | $0.58 | +9.43% | $483.5M | SEC |
| Q4 2024 | Feb 7, 2025 | $0.65 | $0.64 | −1.02% | $521.0M | SEC |
| Q3 2024 | Nov 8, 2024 | $0.59 | $0.62 | +4.91% | $501.9M | SEC |
| Q2 2024 | Invalid Date | $0.56 | $0.60 | +5.66% | $496.3M | — |
| Q1 2024 | May 1, 2024 | $0.47 | $0.50 | +4.95% | $459.0M | SEC |
| Q4 2023 | Feb 8, 2024 | $0.60 | $0.60 | −0.18% | $509.0M | SEC |
| Q3 2023 | Nov 1, 2023 | $0.54 | $0.56 | +3.95% | $475.9M | SEC |
| Q2 2023 | Aug 10, 2023 | $0.56 | $0.57 | +1.62% | $494.9M | SEC |
| Q1 2023 | May 5, 2023 | $0.52 | $0.57 | +9.71% | $485.0M | SEC |
| Q4 2022 | Feb 10, 2023 | $0.52 | $0.59 | +13.22% | $498.0M | SEC |
| Q3 2022 | Nov 9, 2022 | $0.50 | $0.59 | +17.47% | $499.6M | — |
| Q2 2022 | Jul 28, 2022 | $0.51 | $0.57 | +11.69% | $515.5M | — |
| Q1 2022 | Apr 28, 2022 | $0.80 | $0.89 | +12.12% | $628.4M | — |
| Q4 2021 | Feb 9, 2022 | $0.68 | $0.83 | +22.03% | $582.0M | — |
| Q3 2021 | Nov 8, 2021 | $0.60 | $0.65 | +8.28% | $535.0M | — |
Quarterly revenue
Frequently asked questions
When did Qiagen (QGEN) last report earnings?
Qiagen last reported on Aug 7, 2026, covering fiscal Q2 2026.
Did QGEN beat earnings estimates?
Yes. Qiagen reported EPS of $0.62 for Q2 2026 against a $0.60 estimate — a 3.64% beat.
How much revenue did QGEN report last quarter?
Qiagen reported $535.0M in revenue for Q2 2026, against a consensus estimate of $527.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.